drug
methylphenidate hydrochloride XR-ODT
Marketedupdated 3mo agoby $AYTU AYTU BIOPHARMA, INC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval412 co-mentions · 206 sources
- drugMETADATE CD378 co-mentions · 206 sources
- drugMETADATE ER248 co-mentions · 206 sources
- drugRITALIN LA231 co-mentions · 206 sources
- drugQuillivant XR220 co-mentions · 206 sources
- drugMETHYLIN ER219 co-mentions · 206 sources
- drugMethylin219 co-mentions · 206 sources
- drugmethylphenidate hydrochloride ER211 co-mentions · 206 sources
all catalysts(0)
nothing on the calendar yet
Trials studying methylphenidate hydrochloride XR-ODT
- phase3Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD
- phase1Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions
- phase1Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions
- phase4A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 28, 2032
~5.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (12)
- Jan 25, 2038method-of-use (U-3299)US 11166947
- Jan 25, 2038method-of-use (U-3299)US 11166947
- Jan 25, 2038method-of-use (U-3299)US 11166947
- Jun 28, 2032formulationUS 9072680
- Jun 28, 2032formulationUS 9072680
- Jun 28, 2032formulationUS 9072680
- Jun 28, 2032formulationUS 9089496
- Jun 28, 2032formulationUS 9089496
- Jun 28, 2032formulationUS 9089496
- Jun 5, 2026formulationUS 8840924
- Jun 5, 2026formulationUS 8840924
- Jun 5, 2026formulationUS 8840924
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that